Photo Credit: flik47

The following is a summary of “Second Intention Healing After Laser Ablation of Benign Eyelid Margin Tumors,” published in the December 2024 issue of Ophthalmology by Jeon et al. 

Researchers conducted a retrospective study to assess the therapeutic outcomes of benign eyelid margin tumors treated with laser ablation as an alternative to traditional shaving biopsy.  

They included 66 patients with 67 benign eyelid margin tumors (2019–2023). Tumors were removed using either laser ablation or shaving biopsy. The patients were divided into 2 groups: Group 1 (laser-assisted ablation) and Group 2 (shaving excision surgery), 34 cases were treated with laser ablation, while 33 cases underwent shaving excision biopsy. Histologic confirmation was obtained in 11 of the 33 cases treated with shaving excision.  

The results showed no functional or cosmetic complications in Group 1. All cases in Group 1 had clear wound margins after laser-assisted ablation. In Group 2, 1 case exhibited eyelid notching, cilia loss, and 2 had pigmentation changes. No wound infections were reported in either group. The average wound epithelialization duration was 3.3 weeks in Group 1, significantly faster than the 4.2 weeks in Group 2 (P < .01). The average lesion size in Group 1 was 3.0 × 2.9 mm, significantly smaller than the 3.5 × 3.4 mm in Group 2 (P < .05). No recurrences were noted during the follow-up period.  

Investigators concluded the laser ablation was a safe and effective treatment for small benign eyelid margin tumors, resulting in patient satisfaction and no significant complications. 

Source: tandfonline.com/doi/full/10.1080/08820538.2024.2435942